Grangex (GRANGEX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
11 Nov, 2025Executive summary
Net sales for Q3 2025 reached 3,729 KSEK, up from 2,562 KSEK year-over-year.
Operating loss (EBIT) improved to -12,087 KSEK from -18,590 KSEK in Q3 2024.
EPS for Q3 was -2.42 SEK, an improvement from -2.85 SEK year-over-year.
Feasibility study for Sydvaranger mine completed, showing improved metrics over the January PEA.
Major financing and royalty agreements with Anglo American support project development.
Financial highlights
Net sales for Jan–Sep 2025 totaled 17,290 KSEK, up from 14,286 KSEK year-over-year.
Operating loss for Jan–Sep 2025 was -34,830 KSEK, improved from -60,370 KSEK.
Cash and cash equivalents at period end: 22,728 KSEK (110,520 KSEK at 2024 year-end).
Total assets: 1,006 MSEK (919 MSEK year-over-year).
Financial income for Jan–Sep 2025: 91,721 KSEK, mainly from currency effects on USD loans and royalties.
Outlook and guidance
Sydvaranger project moves to execution phase, with first ore deliveries expected Q4 2026.
Final investment decision (FID) for Sydvaranger targeted by end of 2025, contingent on project financing.
Capitalization to include equity issuance and bond financing.
Latest events from Grangex
- Sydvaranger’s restart secures 25 years of DR grade iron ore sales to Anglo American, enabling rapid, low-risk growth.GRANGEX
Stora Aktiedagarna 202610 Mar 2026 - Sydvaranger restart advances with improved results, key financing, and strong project outlook.GRANGEX
Q4 202526 Feb 2026 - Restarting Sydvaranger, Grangex targets premium green steel markets with high-grade iron ore.GRANGEX
Investor presentation27 Jan 2026 - PEA confirms $1.2B NPV, 19-year life, and green steel focus with production by 2027.GRANGEX
Investor Update9 Jan 2026 - DFS confirms US$1.5bn NPV, 25-year life, strong ESG, and full permitting for 2026 restart.GRANGEX
Investor Update30 Sep 2025 - Improved results and project progress, but liquidity shortfall poses going-concern risk.GRANGEX
Q2 202520 Aug 2025 - Revenue fell and losses widened in Q3 2024 as Sydvaranger integration and studies advanced.GRANGEX
Q3 202413 Jun 2025 - Sydvaranger acquisition and Anglo American deals transform Grangex, despite higher H1 losses.GRANGEX
Q2 202413 Jun 2025 - Losses deepened as Grangex advanced major projects and secured key offtake deals.GRANGEX
Q4 20249 Jun 2025